SMC
CCXI

S. Muoio & Co’s ChemoCentryx, Inc. CCXI Stock Holding History

S. Muoio & Co’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3M Buy
+58,000
New +$2.4M 3.96% 5

Other funds holding CCXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

S. Muoio & Co's CCXI Position: Q3 2022 in Review

S. Muoio & Co opened a new position in ChemoCentryx, Inc. (CCXI) in Q3 2022: 58,000 shares worth $3M. The stake represents 3.96% of the portfolio and ranks #5 among its holdings.

217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

  • S. Muoio & Co held 58,000 shares of ChemoCentryx, Inc. worth $3M as of Q3 2022.
  • ChemoCentryx, Inc. was a new S. Muoio & Co position in Q3 2022.
  • ChemoCentryx, Inc. made up 3.96% of S. Muoio & Co's portfolio in Q3 2022, its #5 holding.
  • 217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.